These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16249244

  • 21. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.
    Kwok SK, Ju JH, Cho CS, Kim HY, Park SH.
    Lupus; 2009 Jan; 18(1):16-21. PubMed ID: 19074164
    [Abstract] [Full Text] [Related]

  • 22. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.
    Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D'Cruz D, Griffiths B, Khamashta M, Maddison P, McHugh N, Snaith M, Teh LS, Yee CS, Zoma A, Gordon C.
    Rheumatology (Oxford); 2005 Jul; 44(7):902-6. PubMed ID: 15814577
    [Abstract] [Full Text] [Related]

  • 23. Clinically active serologically quiescent systemic lupus erythematosus.
    Gladman DD, Hirani N, Ibañez D, Urowitz MB.
    J Rheumatol; 2003 Sep; 30(9):1960-2. PubMed ID: 12966598
    [Abstract] [Full Text] [Related]

  • 24. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.
    Nikpour M, Urowitz MB, Ibañez D, Gladman DD.
    Arthritis Rheum; 2009 Sep 15; 61(9):1152-8. PubMed ID: 19714602
    [Abstract] [Full Text] [Related]

  • 25. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T.
    Ann Rheum Dis; 2009 Oct 15; 68(10):1638-43. PubMed ID: 18930996
    [Abstract] [Full Text] [Related]

  • 26. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
    Lee PP, Lee TL, Ho MH, Wong WH, Lau YL.
    Rheumatology (Oxford); 2007 Aug 15; 46(8):1290-6. PubMed ID: 17522097
    [Abstract] [Full Text] [Related]

  • 27. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
    Chang ER, Abrahamowicz M, Ferland D, Fortin PR.
    J Rheumatol; 2002 Nov 15; 29(11):2350-8. PubMed ID: 12415591
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
    Lee PP, Lee TL, Ho MH, Wong WH, Lau YL.
    Pediatr Infect Dis J; 2006 Aug 15; 25(8):728-32. PubMed ID: 16874173
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
    Nephrology (Carlton); 2007 Oct 15; 12(5):474-80. PubMed ID: 17803471
    [Abstract] [Full Text] [Related]

  • 34. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan 15; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 35. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED.
    J Pediatr; 2008 Apr 15; 152(4):550-6. PubMed ID: 18346514
    [Abstract] [Full Text] [Related]

  • 36. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
    Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD, LUMINA Study Group.
    Arthritis Rheum; 2006 May 15; 54(5):1580-7. PubMed ID: 16645994
    [Abstract] [Full Text] [Related]

  • 37. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
    Tan Y, Yu F, Yang H, Chen M, Fang Q, Zhao MH.
    Hum Immunol; 2008 Dec 15; 69(12):840-4. PubMed ID: 18852001
    [Abstract] [Full Text] [Related]

  • 38. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Dec 15; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 39. [Characterization of a Portuguese population with systemic lupus erytematosus].
    Santos MJ, Capela S, Figueira R, Nero P, Matos AA, Silva C, Miranda L, Barcelos A, Marques A, Teixeira A, Branco J, da Silva JC, de Queiroz MV.
    Acta Reumatol Port; 2007 Dec 15; 32(2):153-61. PubMed ID: 17576395
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.